Endothelial cells of oral pyogenic granulomas express eNOS and CD105/endoglin: An immunohistochemical study

Journal of Oral Pathology and Medicine

Volumn 40, Issue 4, 2011, Pages 345-351

  Vassilopoulos, Spyridon I ^a   Tosios, Konstantinos I ^a   Panis, Vassilios G ^a   Vrotsos, John A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Angiogenesis; CD105 endoglin; ENOS; Pyogenic granuloma

Indexed keywords

ENDOGLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ANGIOGENESIS; ARTICLE; ENDOTHELIUM CELL; FEMALE; FIBROSIS; GINGIVA TUMOR; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH TUMOR; PRIORITY JOURNAL; PYOGENIC GRANULOMA; TONGUE TUMOR; TUMOR CLASSIFICATION;

ADULT; ANTIGENS, CD; ENDOTHELIAL CELLS; FEMALE; GINGIVAL DISEASES; GRANULOMA, PYOGENIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOUTH DISEASES; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; TONGUE DISEASES; YOUNG ADULT;

EID: 79952821617     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00969.x     Document Type: Article

References (48)

1. Yuan K, Jin YT, Lin MT. The detection and comparison of angiogenesis - associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol 2000; 71: 701-9.
2. Carmeliet P, Collen D. Molecular analysis of blood vessel formation and disease. Am J Physiol 1997; 273: H2091-104.
3. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-31.
4. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
5. Murata M, Hara K, Saku T. Dynamic distribution of basic fibroblast growth factor during epulis formation: an immunohistochemical study in an enhanced healing process of the gingiva. J Oral Pathol Med 1997; 26: 224-32.
6. Yuan K, Wing LY, Lin MT. Pathogenetic roles of angiogenic factors in pyogenic granulomas in pregnancy are modulated by female sex hormones. J Periodontol 2002; 73: 701-8.
7. Dulak J, Józkowicz A, Dembinska-Kiec A, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 659-66.
8. Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998; 274: H1054-8.
9. Tiefenbacher CP, Chilian WM. Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation. Cardiovasc Res 1997; 34: 411-7.
10. Wu HM, Yuan Y, Mccarthy M, Granger HJ. Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism. Am J Physiol 1996; 271: H1087-93.
11. Hayashi T, Yano K, Matsui-Hirai H, Yokoo H, Hattori Y, Iguchi A. Nitric oxide and endothelial cellular senescence. Pharmacol Ther 2008; 120: 333-9.
12. Cooke JP. NO and angiogenesis. Atheroscler Suppl 2003; 4: 53-60.
13. Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-34.
14. Jerkic M, Rivas-Elena JV, Prieto M, et al. Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 2004; 18: 609-11.
15. Toporsian M, Gros R, Kabir MG, et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005; 96: 684-92.
16. Bellon T, Corbi A, Lastres P, et al. Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 1993; 23: 2340-5.
17. Bernabeu C, Conley BA, Vary CPH. Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem 2007; 102: 1375-88.
18. Buhring HJ, Muller CA, Letarte M, et al. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow. Leukemia 1991; 16: 911-8.
19. Ten Dijke P, Goumans MJ, Pardali E. Endoglin in angiogenesis and vascular diseases. Angiogenesis 2008; 11: 79-89.
20. Guerrero-Esteo M, Lastres P, Letamendia A, et al. Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts. Eur J Cell Biol 1999; 78: 614-23.
21. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J Biol Chem 1999; 274: 584-94.
22. Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, Kumar S. CD105 antagonizes the inhibitory signaling of transforming growth factor β1 on human vascular endothelial cells. FASEB J 2000; 14: 55-64.
23. Neville BW, Damm DD, Allen CM, Bouqouot JE. Oral and maxillofacial pathology, 3rd edn. St Louis MI: WB Saunders, 2009, 518-9.
24. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995; 177: 275-83.
25. Svrivastava A, Laidler P, Hughes L, Woodcock J, Shedden EJ. Neovascularization in human cuntaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986; 22: 1205-9.
26. Charpin C, Devictor B, Bergeret D, et al. CD 31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. Am J Clin Pathol 1995; 103: 443-8.
27. Gil J, Wu H, Wang B. Image analysis and morphometry in the diagnosis of breast cancer. Microsc Res Tech 2002; 59: 109-18.
28. Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci 2005; 7: 65-9.
29. Yuan K, Jin YT, Lin MT. Expression of Tie-2, angiopoietin-1, ephrin B2 and EphB4 in pyogenic granuloma of human gingival implicates their roles in inflammatory angiogenesis. J Periodontal Res 2000; 35: 165-71.
30. Yuan K, Lin MT. The roles of vascular endothelial growth factor and angiopoietin-2 in the regression of pregnancy pyogenic granuloma. Oral Dis 2004; 10: 179-85.
31. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, Harrison DG. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol 1995; 15: 1255-61.
32. Yoon HJ, Cho SW, Ahn BW, Yang SY. Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells. Mech Ageing Dev 2010; 131: 119-23.
33. Donato AJ, Gano LB, Eskurza I, et al. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 2009; 297: H425-32.
34. Yang YM, Huang A, Kaley G, Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol 2009; 297: H1829-36.
35. Smith AR, Hagen TM. Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid. Biochem Soc Trans 2003; 31: 1447-9.
36. Ηishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 1995; 360: 291-3.
37. Rosenfeld CR, Cox BE, Roy T, Magnes RR. Nitric oxide contributes to estrogen induced vasodilation of the ovine uterine circulation. J Cell Sci 1996; 98: 2158-66.
38. Hisamoto K, Ohmichi M, Kurachi H, et al. Estrogen induces the Akt dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001; 276: 3459-67.
39. Russel KS, Haynes MP, Sinha D, Clerisme E, Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 2000; 97: 5930-5.
40. Haynes MP, Li L, Sinha D, et al. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 2003; 278: 2118-22.
41. Nichols GE, Gaffey MJ, Mills SE, Weiss LM. Lobular capillary hemangioma. An immunohistochemical study including steroid hormone receptor status. Am J Clin Pathol 1992; 97: 770-5.
42. Whitaker SB, Bouquot JE, Alimario AE, Whitaker TJ. Identification and semiquantification of estrogen and progesterone receptors in pyogenic granulomas of pregnancy. Oral Surg Oral Med Oral Pathol 1994; 78: 755-60.
43. Hisamoto K, Bender JR. Vascular cell signaling by membrane estrogen receptors. Steroids 1998; 70: 382-7.
44. Bourdeau A, Faughnan ME, Letarte M. Endoglin-deficient mice, a unique model to study hereditary haemorrhagic telangiectasia. Trends Cardiovasc Med 2000; 10: 279-85.
45. Li DY, Sorensen L, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science 1999; 284: 1534-7.
46. Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. Lyon: ARC Press, 2005: 46-8.
47. Lawoyin JO, Arotiba JT, Dosumu OO. Oral Pyogenic granuloma: a review of 38 cases from Ibadan, Nigeria. Br J Oral Maxillofac Surg 1997; 37: 185-94.
48. Regezi JA, Sciubba JJ, Jordan RCK. Oral pathology: clinical pathologic considerations, 4th edn. Philadelphia: WB Saunders, 2003: 115-6.